Slide continues: Novonix share price dumps 14% in 2 days

Novonix extends losses this week

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Novonix shares extended their slide today 
  • Investors weren't satisfied with the company's FY22 results, despite an increase of investment in the company
  • The Novonix share price is down 77% this year to date

The Novonix Ltd (ASX: NVX) share price traded deep in the red on Friday, extending losses over the past two trading days to almost 15%.

By Friday's close, the Novonix share price was down 8% for the day at $2.07, on a volume of 6.24 million shares – ahead of the 4-week trading average of 4.9 million shares.

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.

Image source: Getty Images

What's up with the Novonix share price?

The share has seen heavy selling activity ever since the company posted its FY22 full-year earnings results. It was a busy year for the battery technology company.

Revenues were booked at $8.4 million, although cash from operations and net profit both slipped year on year as the company ramped up its investment back into the business.

The bedrock of this activity was formed via an investment from Philips 66 back in 2021, following its strategic stake in the company for $203 million.

Despite the heavy investment activity, the company didn't provide any earnings guidance for the coming 12 months.

Perhaps it is this point that has investors worried about the Novonix share price.

In the prevailing market circumstances, investors aren't paying a premium for unprofitable companies like they were in 2020–2021.

That's seen in the large wind down in growth-backed indices and ETFs tracking ASX growth shares. For instance, the S&P/ASX 200 Growth Index is down 14% this year, while the Vanguard Diversified High Growth Index ETF (ASX: VDHG) is down a similar amount.

That comes in behind the benchmark S&P/ASX 200 Index (ASX: XJO)'s 8% loss for the year.

What else could be impacting Novonix shares?

Adding to the downside, ASX materials stocks have taken a nosedive since late August and finished down more than 9% on the week.

Whilst Novonix is an ASX tech share by GICS Industry classification, it has exposure to various commodities through purchase orders.

Losses stemmed on the back of further lockdowns in Chinese megacity Chengdu, located in the west of the country.

The lockdown will last for 4 days but could be extended for the city of 21 million people if COVID-19 cases continue to rise.

"The city is the capital of Sichuan province, which has already been hit by severe drought and floods in recent weeks. A power crisis caused by the heatwave forced some factories in the province to shut last month," Bloomberg reported today.

"[Chengdu] city's economy expanded just 3%, well below the 13.1% it grew in the same period in 2021," it added.

On the back of the news, Brent crude, gasoline and gold posted gains on Friday, whilst lithium was flat at the close.

In fact, lithium carbonate prices remain as buoyant as ever, a point that has implications on the outlook for Novonix in its future purchasing prices of the battery metal.

Meanwhile, the Novonix share price is down 77% this year to date.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 4DMedical, New Hope, Santos, and St George Mining shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Fallers

These 3 dirt-cheap ASX shares are tipped to climb another 50-90%

These shares are now trading at super low prices.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why DroneShield, Hub24, Syrah, and Weebit Nano shares are sinking today

These shares are ending the week in the red. But why?

Read more »

A worried woman sits at her computer with her hands clutched at the bottom of her face.
Share Fallers

These 3 ASX 200 shares have hit fresh multi-year lows: Buy, sell or hold?

One of these stocks has crashed over 50% over the past year alone.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Brazilian Rare Earths, L1 Group, Silver Mines, and Xero shares are dropping today

These shares are having a poor session on Thursday. But why?

Read more »